Ella Li, Ph.D.
Dr. Ella Li the CEO of Hanhai BioLabs, leading their team in life science investment, acceleration and globalization to transform healthcare. She is also the founder of M7 Healthcare Accelerator, providing acceleration, funding, and key resources to startups in healthcare sectors. Dr. Li is the former CEO of ZGC Capital and the partner of its U.S. funds, and has established and managed several VC and fund of funds, including one with portfolio funds including KPCB, Menlo, Andreessen Horowitz, Accel, Foundation Capital, and IVP. Dr. Li has 10+ years of experience in biotech research and has rich experiences in therapeutic investment opportunities from discovery and clinical proof-of-concept to commercialization. She also serves as board advisor, consultant and advisor for several global accelerators, VCs and startups. Dr. Ella Li earned her B.S. and M.S. degrees from Peking University, and her Ph.D. from the University of Texas Health Science Centers. She completed her postdoctoral fellowship from Harvard Medical School, where she led five independent projects exploring novel therapeutic targets for metabolic disease. Ella has extensive publications in prestigious journals with IMF over 10 including Nature Communication, Cell Metabolism, Journal of Clinical Investigation, PNAS, Molecular Cell, Diabetes etc. with 800+ citations.